Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells.
D'Atri, S
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells. [electronic resource] - Immunopharmacology - 199-210 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0162-3109
10.1016/0162-3109(91)90025-t doi
Antigens, Neoplasm
Antineoplastic Agents--pharmacology
Cell Line
Cytotoxicity, Immunologic
HLA Antigens
Humans
Killer Cells, Lymphokine-Activated--immunology
Killer Cells, Natural--immunology
Lung Neoplasms--drug therapy
Triazenes--pharmacology
Tumor Cells, Cultured--drug effects
Drug-mediated increase of susceptibility of human lung cancer to NK or LAK effector cells. [electronic resource] - Immunopharmacology - 199-210 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0162-3109
10.1016/0162-3109(91)90025-t doi
Antigens, Neoplasm
Antineoplastic Agents--pharmacology
Cell Line
Cytotoxicity, Immunologic
HLA Antigens
Humans
Killer Cells, Lymphokine-Activated--immunology
Killer Cells, Natural--immunology
Lung Neoplasms--drug therapy
Triazenes--pharmacology
Tumor Cells, Cultured--drug effects